Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

Europe - EPA:UBI - FR0000054470 - Common Stock

7.95 EUR
-0.64 (-7.41%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

Overall UBI gets a fundamental rating of 3 out of 10. We evaluated UBI against 45 industry peers in the Entertainment industry. The financial health of UBI is average, but there are quite some concerns on its profitability. UBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year UBI has reported negative net income.
UBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UBI reported negative net income in multiple years.
UBI had a positive operating cash flow in each of the past 5 years.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

The Return On Assets of UBI (-3.38%) is comparable to the rest of the industry.
UBI has a Return On Equity (-8.86%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

UBI has a better Gross Margin (89.33%) than 77.78% of its industry peers.
In the last couple of years the Gross Margin of UBI has remained more or less at the same level.
UBI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

UBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UBI has been increased compared to 1 year ago.
UBI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UBI has been reduced compared to a year ago.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that UBI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.10, UBI is in line with its industry, outperforming 44.44% of the companies in the same industry.
UBI has a debt to FCF ratio of 2.24. This is a good value and a sign of high solvency as UBI would need 2.24 years to pay back of all of its debts.
The Debt to FCF ratio of UBI (2.24) is better than 66.67% of its industry peers.
UBI has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
UBI has a worse Debt to Equity ratio (1.02) than 60.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for UBI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Altman-Z 1.1
ROIC/WACCN/A
WACC5.73%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.68, UBI belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
A Quick Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.68, UBI belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

UBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.28%.
The Revenue for UBI has decreased by -17.46% in the past year. This is quite bad
Measured over the past years, UBI shows a small growth in Revenue. The Revenue has been growing by 3.56% on average per year.
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%

3.2 Future

The Earnings Per Share is expected to grow by 33.62% on average over the next years. This is a very strong growth
Based on estimates for the next years, UBI will show a small growth in Revenue. The Revenue will grow by 5.14% on average per year.
EPS Next Y30.99%
EPS Next 2Y75.71%
EPS Next 3Y64.8%
EPS Next 5Y33.62%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y5.25%
Revenue Next 5Y5.14%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UBI. In the last year negative earnings were reported.
Also next year UBI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UBI is valued cheaply inside the industry as 91.11% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UBI is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.11
EV/EBITDA 3.3
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as UBI's earnings are expected to grow with 64.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.71%
EPS Next 3Y64.8%

0

5. Dividend

5.1 Amount

No dividends for UBI!.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (10/17/2025, 7:00:00 PM)

7.95

-0.64 (-7.41%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-22 2025-07-22
Earnings (Next)11-13 2025-11-13
Inst Owners40.77%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.07B
Analysts55
Price Target11.42 (43.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-144.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF 1.11
P/OCF 1.06
P/B 0.6
P/tB N/A
EV/EBITDA 3.3
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)7.18
FCFY90.37%
OCF(TTM)7.5
OCFY94.28%
SpS14.11
BVpS13.34
TBVpS-3.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.33%
FCFM 50.92%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Debt/EBITDA 2.7
Cap/Depr 5.9%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion 148.22%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 1.1
F-Score3
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
EPS Next Y30.99%
EPS Next 2Y75.71%
EPS Next 3Y64.8%
EPS Next 5Y33.62%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y5.25%
Revenue Next 5Y5.14%
EBIT growth 1Y-109.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1298.26%
EBIT Next 3Y172.2%
EBIT Next 5Y83.56%
FCF growth 1Y129.47%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y87.67%
OCF growth 3Y12.65%
OCF growth 5Y10.94%